Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of (NY:FMS)

26.84 +0.16 (+0.60%)
Official Closing Price Updated: 6:30 PM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of

< Previous 1 2 3 4 Next >
This Fortinet Analyst Turns Bearish; Here Are Top 5 Downgrades For Tuesday
 
Via Benzinga
Amphastar Secures FDA Nod For Iron Sucrose Injection, Analysts Eye Major Sales Momentum
FDA approves Amphastar's iron sucrose injection for CKD-associated anemia, with potential for $80-100 million sales and a 2025 launch. 
Via Benzinga
Dollar's Worst Start Since 1970s Could Dent European Corporate Profits
 
Via Benzinga
Aurora Cannabis, Bitdeer Technologies Group And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
 
Via Benzinga
Topics Cannabis
Earnings Scheduled For May 6, 2025
 
Via Benzinga
Earnings Scheduled For February 25, 2025
 
Via Benzinga
Fresenius Medical Care Launches Value-Based Care Segment, Eyes Growth Through Innovation, Efficiency
Fresenius Medical Care outlines new strategy with 5008X machine rollout in the U.S., launch of Value-Based Care segment, and cost-saving goals through FME25+. 
Via Benzinga
5 Stocks To Ride The German Market Rally
 
Via Benzinga
FARO Technologies, Celanese, Avient, Aramark And Other Big Stocks Moving Higher On Tuesday
 
Via Benzinga
Quest Diagnostics Revenue Rebound, Strategic Moves Fuel Outlook Confidence
Quest Diagnostics Q1 2025 revenue rose to $2.65 billion with EPS of $2.21, exceeding expectations; full-year guidance for sales and EPS reaffirmed. 
Via Benzinga
Lamb Weston Posts Better-Than-Expected Results, Joins Sanofi And Other Big Stocks Moving Higher On Thursday
 
Via Benzinga
5 Classic Value Stocks For 2025
Alaska Air Group had a big year in 2024 as it closed on its deal for Hawaiian Airlines in September. It now flies to over 141 destinations. 
Via Talk Markets
Topics Stocks / Equities
Donald Trump's Second Term Could Reshape US Healthcare System, With Major Impacts on Affordable Care Act And Medicare
Trump's second term could bring significant changes to U.S. healthcare, with cuts to ACA subsidies and potential Medicare privatization. 
Via Benzinga
Topics Government
Current Analysis: Fresenius Medical Care (FMS)
Fresenius Medical Care (FMS​​​​​​​) is the largest dialysis company in the world. Over the past year, Fresenius's share price fell just over 30% from $26.09 to $18.14 as of Monday’s market close. 
Via Talk Markets
Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
 
Via Benzinga
Lattice Semiconductor Posts Weak Q2 Results, Joins Symbotic, Woodward And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
 
Via Benzinga
Stock Analysis: Fresenius Medical Care
Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients from over 4,100 clinics across the globe as of December 2022. 
Via Talk Markets
Buffett Buys on a Budget: The 3 Cheapest Stocks Held by Berkshire Hathaway
You can't go wrong by following in the Oracle's footsteps and buying these cheap Buffett stocks before the market catches on. 
Via InvestorPlace
Fresenius SE's Future With Dialysis Company Unclear, Investors Seek Answers
Investors urge Fresenius SE to clarify its strategic plans for Fresenius Medical Care after recent deconsolidation. Despite holding a 32% stake, challenges like high dialysis patient mortality and... 
Via Benzinga
Current Analysis: Fresenius Medical Care
Fresenius Medical Care is the largest dialysis company in the world and a leading supplier of dialysis products, including machines, dialyzers, and concentrates. 
Via Talk Markets
Topics Supply Chain
FMS Stock Earnings: Fresenius Medical Care Beats EPS, Beats Revenue for Q1 2024
FMS stock results show that Fresenius Medical Care beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
AudioCodes Reports Downbeat Earnings, Joins Trupanion, Palantir Technologies And Other Big Stocks Moving Lower In Tuesday Pre-Market Session
 
Via Benzinga
Matterport, Sea Limited, Ingevity And Other Big Stocks Moving Higher On Monday
 
Via Benzinga
Why Are Dialysis Provider Stocks Trading Higher On Tuesday?
Novo Nordisk's FLOW trial reveals a 24% reduction in kidney disease progression, cardiovascular events, and death with semaglutide 1.0 mg compared to placebo. Impact on dialysis stocks 
Via Benzinga
Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expected fourth-quarter earnings and issued 2024 guidance. 
Via Benzinga
NIO Reports Upbeat Earnings, Joins Dave, V2X, Riskified And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were lower, with the Dow Jones index falling more than 200 points on Tuesday. 
Via Benzinga
Topics Stocks
Why Dialysis Stocks DaVita, Fresenius Soared On Novo's Ozempic News
Novo Nordisk tested its diabetes and weight-loss drug in patients with chronic kidney disease. 
Via Investor's Business Daily
Stock Market Whiplash
We've also got a look at the international real estate market. 
Via The Motley Fool
Dialysis Player Fresenius Medical's Q4 Sales Hold Steady: Details
Fresenius Medical Care Q4 2023 revenue: €4.9 billion. Patient volume growth is expected at 0.5%-2% in 2024. 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.